Keywords: CT; computed tomography; CEA; carcinoembryonic antigen; CA 19-9; carbohydrate antigen 19-9; PET; positron emission tomography; FDG; fluorodeoxyglucose; US; ultrasound sonography; MRI; magnetic resonance imaging; Hemolymphangioma; Retroperitoneal tumor;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: FAP; familial adenomatous polyposis; CT; computed tomography; CEA; carcinoembryonic antigen; CA 19-9; carbohydrate antigen 19-9; PET; positron emission tomography; FDG; fluorodeoxyglucose; SUVmax; maximum standard uptake value; Case report; Intra-abdomina
Keywords: ESR; Erythrocyte Sedimentation Rate; ADA; Adenosine Deaminase; CT; Computerized Tomography; CEA; Carcino Embryonic Antigen; CA 19-9; Cancer Antigen 19-9; AKT; Anti Koch's Treatment; MTB; Mycobacterium Tuberculosis; IBD; Inflammatory Bowel Disease; GITB;
Keywords: Ca 19-9; Hamartomas; Biliar; Von Meyenburg; Benigno; Ca 19-9; Hamartomas; Biliary; Von Meyenburg; Benign;
Keywords: CA 19-9; cancer antigen 19-9; CEA; carcinoembryonic antigen; CT; computed tomography; MRI; magnetic resonance imaging; PET; positron emission tomography; GIST; gastrointestinal stromal tumor; H&E; hematoxylin and eosin; Gastrointestinal stromal tumor (GIS
Keywords: APC; advanced pancreatic cancer; aPTT; activated partial thromboplastin time; CA 19-9; carbohydrate antigen 19-9; HR; hazard ratio; KPS; Karnofsky performance status; LMWH; low molecular weight heparin; OS; overall survival; PC; pancreatic cancer; QoL; qu
Keywords: Diabetes mellitus; Pancreatic cancer; Screening; Ca 19-9; Abdominal ultrasonography; Standardized incidence ratio;
Keywords: CA-125; CA 19-9; diagnostic marker; endometriosis; follistatin
Keywords: Ureteropelvic junction obstruction; CA 19-9; Urinary biomarkers; Hydronephrosis;
Keywords: Chemotherapy; Imaging; Pancreatic cancer; Pathology; Radiotherapy; Targeted therapy; 18FDG-PET; 18F-fluorodeoxyglucose-positron emission tomography; 5FU; 5-fluorouracil; α-SMA; α-smooth muscular actin; AA; amino acid; APA; adapted physical activity; ATP
Keywords: Molecular; Chromosomal Abnormalities; Genetics; Tumor; CA 19-9; carbohydrate antigen 19-9; CEP; chromosome enumeration probe; ERCP; endoscopic retrograde cholangiopancreatography; FFPE; formalin-fixed paraffin-embedded; FISH; fluorescence in situ hybridiz
Keywords: CA 19-9; Granulocyte-colony stimulating factor; Nab-paclitaxel; Response; Toxicity
A case of ascending colon cancer accompanied with tumor thrombosis in the superior mesenteric vein treated with right hemicolectomy and greater saphenous vein grafting
Keywords: SMV; superior mesenteric vein; IMV; inferior mesenteric vein; CT; computed tomography; CEA; carcinoembryonic antigen; CA 19-9; cancer antigen 19-9; PET; positron emission tomography; FDG; fluorodeoxyglucose; SUV; standardized uptake value; ICV; ileocolic
Fast detection of tumor marker CA 19-9 using AlGaN/GaN high electron mobility transistors
Keywords: Nitride-HEMT; CA 19-9; Biosensor; Microfluidic channel;
The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis
Keywords: PDAC; pancreatic ductal adenocarcinoma; CA 19-9; carbohydrate antigen 19-9; Pancreatic neoplasms; Recurrence; Follow-up studies; Pancreatectomy; Diagnostic imaging;
Development of quantitative immunochromatographic assay for rapid and sensitive detection of carbohydrate antigen 19-9 (CA 19-9) in human plasma
Keywords: Lateral flow; Biosensor; Gold nanoparticle; CA 19-9; Quantitative; Immunochromatographic;
Ultrasensitive photoelectrochemical immunoassay for CA19-9 detection based on CdSe@ZnS quantum dots sensitized TiO2NWs/Au hybrid structure amplified by quenching effect of Ab2@V2+ conjugates
Keywords: Photoelectrochemistry; Immunoassay; Quenching effect; Synergy effect; CA 19-9;
Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus
Keywords: miRNA; Pancreatic cancer; Biomarker; CA 19-9;
Serum CA 19-9 as a good prognostic biomarker in patients with bladder cancer
Keywords: CA 19-9; Bladder tumor; Prognosis
High serum CA 19-9 but not tumor size should select patients for staging laparoscopy in radiological resectable pancreas head and peri-ampullary cancer
Keywords: Pancreas cancer; Peri-ampullary cancer staging laparoscopy; CA 19-9
Original scientific articleOutcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models
Keywords: CA 19-9; cancer antigen 19-9; C-index; concordance index; ICC; intrahepatic cholangiocarcinoma; LN; lymph node; MSKCC; Memorial Sloan Kettering Cancer Center; OS; overall survival;
Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms
Keywords: Carcinoembryonic antigen (CEA); Carbohydrate antigen 125 (CA 125); Cyst fluid analysis; Cytology; Mucinous cystic lesions; Mucinous cystic neoplasm (MCN); AUC; area under receiver operating characteristic curve; CEA; carcinoembryonic antigen; CA 19-9; car
Cystic Neoplasms of the Liver: Biliary Cystadenoma and Cystadenocarcinoma
Keywords: BCA; biliary cystadenoma; BCAC; biliary cystadenocarcinoma; BCT; biliary cystic tumor; CA 19-9; carbohydrate antigen 19-9; IPMN; intraductal papillary mucinous neoplasm;
CEA, AFP and CA 19-9 analysis in peritoneal fluid to differentiate causes of ascites formation
Keywords: Tumor marker analysis; Ascites; CA 19-9; CEA; AFP
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study
Keywords: Pancreatic cancer; Tumor marker; CEA; CA 19-9; SurgeryPDAC, pancreatic ductal adenocarcinoma; CEA, carcinoembryonic antigen; CA 19-9, carbohydrate-antigen 19-9
Diagnosis of isolated pancreatic tuberculosis: the role of EUS-guided FNA cytology
Keywords: AFB; acid-fast bacilli; ATT; antituberculosis treatment; CA 19-9; carbohydrate antigen 19-9; EUS-FNA; EUS-guided FNA; EUS-FNAC; EUS-guided FNA cytology; TB; tuberculosis;
Radiofrequency Ablation in the Management of Unresectable Intrahepatic Cholangiocarcinoma
Keywords: CA 19-9; cancer antigen 19-9; HCC; hepatocellular carcinoma; ICC; intrahepatic cholangiocarcinoma; RF; radiofrequency; R0; resection margin; UICC; Union for International Cancer Control;
Radiofrequency Ablation of Liver Metastasis in Patients with Locally Controlled Pancreatic Ductal Adenocarcinoma
Keywords: CA 19-9; cancer antigen 19-9;
CA 19-9 Level in Patients With Type 2 Diabetes Mellitus and Its Relation to the Metabolic Control and Microvascular Complications
Keywords: Type 2 diabetes mellitus; CA 19-9; Microvascular complications; Glycated hemoglobin;
Diagnostic Validity of Serum Macrophage Inhibitor Cytokine and Tissue Polypeptide-Specific Antigen in Pancreatobiliary Diseases
Keywords: Pancreatic cancer; Pancreatobiliary diseases; Macrophage inhibitory cytokine 1; Tissue polypeptide-specific antigen; CA 19-9; Tumor marker;
CA 19-9 Level as Indicator of Early Distant Metastasis and Therapeutic Selection in Resected Pancreatic Cancer
Keywords: Pancreatic cancer; Distant metastasis; Carbohydrate antigen 19-9; CA 19-9;
Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma
Keywords: Bile Duct; Liver Disease; Biliary Tract Cancer; Cancer Diagnostic; AUC; area under the curve; CA 19-9; carbohydrate antigen 19-9; CCA; cholangiocarcinoma; NPV; negative predictive value; PPV; positive predictive value; PSC; primary sclerosing cholangitis;
Pretreatment Carbohydrate Antigen 19-9 Level Indicates Tumor Response, Early Distant Metastasis, Overall Survival, and Therapeutic Selection in Localized and Unresectable Pancreatic Cancer
Keywords: Pancreatic cancer; Overall survival; Distant metastasis; CA 19-9; Chemoradiotherapy;
Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System
Keywords: CA 15-3; CA 19-9; CA 125 II; CEA; AFP; Assays; Dimension Vista® System
How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects?
Keywords: Asymptomatic patient; CA 19-9; Pancreatic cancer; Tumor marker
CA 19-9 as a Predictor for Response and Survival in Advanced Pancreatic Cancer Patients Treated With Chemoradiotherapy
Keywords: Pancreatic cancer; CA 19-9; Chemoradiotherapy; Tumor response; Survival;
Persistent elevation of serum CA 19-9 with no evidence of malignant disease
Keywords: CA 19-9; Tumour markers
Une péricardite atypique
Keywords: Kyste bronchogénique; Péricarde; Péricardite; CA 19-9; Tumeurs médiastinales; Tumeurs péricardiques; Bronchogenic cyst; Pericardium; Pericarditis; CA 19-9; Mediastinal tumours; Pericardial tumours;
The Use of Adjusted Preoperative CA 19-9 to Predict the Recurrence of Resectable Pancreatic Cancer
Keywords: adjusted; CA 19-9; resection; pancreatic cancer; recurrence
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
Keywords: Serum tumour markers; Pancreatic neoplasm; CA 19-9; CA 50; CEA
A disposable two-throughput electrochemical immunosensor chip for simultaneous multianalyte determination of tumor markers
Keywords: Bioanalysis; Biosensors; Immunosensor; Electrochemistry; Multianalyte determination; Biochip; Tumor marker; CA 19-9; CA 125
CA 19-9 Levels Predict Results of Staging Laparoscopy in Pancreatic Cancer
Keywords: CA 19-9; laparoscopy; pancreatic cancer;
An evidence-based approach to the diagnosis and staging of pancreatic cancer
Keywords: CA 19-9; Computed tomography; Diagnosis; Endoscopic ultrasonography; Pancreatic cancer; Staging;